IonQ drops with quantum peers into year-end, as investors weigh next catalysts

IonQ drops with quantum peers into year-end, as investors weigh next catalysts

NEW YORK, December 28, 2025, 9:31 PM ET — Market closed

  • IonQ shares ended the last session down 7.6% at $46.00, after trading as low as $45.78.
  • Other U.S.-listed quantum-computing stocks also slid, with D-Wave down about 8.1%, Rigetti down 8.6% and Quantum Computing Inc down 6.5%.
  • Recent IonQ updates have centered on new system deals in South Korea and Switzerland, announced on Dec. 23 and Dec. 17. 1

IonQ shares fell 7.6% to $46.00 in their last U.S. session on Friday, retreating with other quantum-computing stocks into the final days of the year.

The move matters because IonQ is one of a small set of publicly traded “pure plays” in quantum computing — companies whose main business is building quantum hardware and services — and the group has been prone to sharp swings on relatively little news. 2

With the sector still early in commercial adoption, traders have been treating customer deals and roadmaps as key markers for progress, even as near-term earnings remain volatile. 2

IonQ traded between $45.78 and $50.08 in the session and ended on volume of about 19.7 million shares, according to market data.

The drop was broadly in line with peers. D-Wave Quantum closed down about 8.1%, Rigetti Computing fell about 8.6% and Quantum Computing Inc slid about 6.5%, based on the same data.

IonQ’s most recent company update came on Dec. 23, when it said it finalized an agreement with South Korea’s Korea Institute of Science and Technology Information (KISTI) to deliver a 100-qubit “Tempo” quantum system. 1

A qubit is the basic unit of information in a quantum computer; a higher qubit count can enable more complex calculations, though performance also depends on how often the machine makes errors.

“This is a defining moment for both IonQ and South Korea,” Chief Executive Niccolo de Masi said in the statement. 1

IonQ said the system will be integrated into KISTI-6 (“HANKANG”), a high-performance computing cluster, and made available through a secure private cloud — a “hybrid” setup that pairs quantum processors with conventional computing. 1

Earlier, on Dec. 17, IonQ said it expanded its partnership with Switzerland’s QuantumBasel, a deal it said lifts the total value above $60 million and extends its on-site presence in Switzerland through 2029. 3

IonQ sells access to its quantum computers through cloud platforms including Amazon Web Services’ Amazon Braket, Microsoft’s Azure Quantum and Google’s Cloud Marketplace, according to company information on Reuters. 2

Before Monday’s session, traders will be watching whether IonQ can hold above the late-week low around $45.78. A move back through the $50 area would put the recent slide in a different light after Friday’s swing.

Investors are also looking for the next catalyst — whether that comes from additional customer wins, fresh contract details tied to recent deals, or the company’s next quarterly update — at a time when thin holiday liquidity can magnify price moves in smaller, risk-sensitive stocks. 1

Stock Market Today

Reckitt share price ends week near a one-year high as RKT investors eye special dividend and March results

Reckitt share price ends week near a one-year high as RKT investors eye special dividend and March results

7 February 2026
London, Feb 7, 2026, 08:16 GMT — Market closed. Reckitt Benckiser Group (RKT.L) shares ended Friday at 6,400 pence, down 0.2%, after touching a one-year high of 6,432 pence. About 2.6 million shares changed hands. 1 The stock is now trading through the tail-end of a chunky one-off cash return. Reckitt has set a 235 pence-a-share special dividend for Feb. 20 and is pairing it with a 24-for-25 share consolidation to keep the quoted share price and per-share metrics broadly comparable after the payout. 2 In the wider market, Britain’s FTSE 100 finished Friday up 0.6%, with gains in heavyweight
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Coupang stock in focus after $1.18 billion data-leak voucher plan
Previous Story

Coupang stock in focus after $1.18 billion data-leak voucher plan

Merck stock holds near 52-week high as year-end trading turns to Fed minutes
Next Story

Merck stock holds near 52-week high as year-end trading turns to Fed minutes

Go toTop